ATRANDI BIOSCIENCES
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
ATRANDI BIOSCIENCES
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Vilnius, Vilniaus Apskritis, Lithuania
Country:
Lithuania
Website Url:
http://www.atrandi.com
Total Employee:
11+
Status:
Active
Total Funding:
6.01 M USD
Technology used in webpage:
CrUX Dataset CrUX Top 10m ASP.NET Core
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Core Biogenesis
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Karolis Leonavicius Chief Technology Officer @ Atrandi Biosciences
Chief Technology Officer
Rapolas Zilionis Chief Scientific Officer @ Atrandi Biosciences
Chief Scientific Officer
Linas Mazutis Founder and Scientific Advisor @ Atrandi Biosciences
Founder and Scientific Advisor
Juozas Nainys CEO @ Atrandi Biosciences
CEO
2018-05-01
Founder
Investors List
Vsquared Ventures
Vsquared Ventures investment in Series A - Atrandi Biosciences
Practica Capital
Practica Capital investment in Series A - Atrandi Biosciences
Metaplanet
Metaplanet investment in Series A - Atrandi Biosciences
Practica Capital
Practica Capital investment in Seed Round - Atrandi Biosciences
Official Site Inspections
http://www.atrandi.com Semrush global rank: 3.99 M Semrush visits lastest month: 2.74 K
- Host name: ec2-13-51-93-209.eu-north-1.compute.amazonaws.com
- IP address: 13.51.93.209
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Atrandi Biosciences"
About Us | Atrandi Biosciences
About us We are a pioneering life sciences tool company dedicated to advancing our understanding of biology through cutting-edge single-cell technologies. Our name Atrandi, meaning “you discover” in Lithuanian, embodies our mission to …See details»
Atrandi Biosciences
This enables the simultaneous processing of all cells within a single bulk reaction, while maintaining single-cell resolution for each. Created by the Atrandi team, this breakthrough …See details»
Atrandi Biosciences - Crunchbase Company Profile
Atrandi Biosciences is a privately held biotechnology company specializing in next-generation single-cell technology, particularly in single-cell eukaryotic …See details»
Atrandi Biosciences 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Atrandi Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Atrandi Biosciences - Funding, Financials, Valuation & Investors
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.See details»
Atrandi Biosciences Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Atrandi Biosciences. See Atrandi Biosciences company profile and funding data.See details»
Atrandi Biosciences Secures Funding
Mar 28, 2023 Atrandi Biosciences (www.atrandi.com) is an emerging developer and provider of innovative microfluidic solutions for the life sciences. Its novel technology platform enables …See details»
Atrandi Biosciences - VentureRadar
Atrandi Biosciences is an emerging developer and provider of microfluidic solutions for the life sciences. Its technology platform enables insights into the biology of single cells, with …See details»
Atrandi Biosciences, Inc. (Atrandi Biosciences, Inc.) - 药物管线_专 …
About Atrandi Biosciences Atrandi Biosciences ( www.atrandi.com ) is an emerging developer and provider of innovative microfluidic solutions for the life sciences. Its novel technology platform …See details»
Atrandi Biosciences, Inc. - CMOCRO
Atrandi Biosciences is an emerging developer and provider of innovative microfluidic solutions for the life sciences. Its novel technology platform enables new insights into the biology of single …See details»
Atrandi Biosciences - Overview, News & Similar companies
View Atrandi Biosciences (www.atrandi.com) location in Vilnius County, Lithuania , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Series A - Atrandi Biosciences - 2025-02-18 - Crunchbase
Feb 18, 2025 Atrandi Biosciences raised $25000000 on 2025-02-18 in Series ASee details»
Atrandi Biosciences Raises $25M Series A Led by Lux Capital
Feb 19, 2025 VILNIUS, LITHUANIA – February 18, 2025 – Atrandi Biosciences, a life sciences company pioneering next-generation single-cell analysis technology, today announced a $25 …See details»
Lithuanian biotech company secures $25M to expand single-cell …
Feb 19, 2025 Atrandi previously raised $4.8 million in 2023 and now plans to open a Boston office as part of its growth strategy. Atrandi Biosciences is a biotechnology company focused …See details»
Atrandi Biosciences - Inospectra
Lithuanian company Atrandi Biosciences develops modern, easily adaptable solutions and tools for high-throughput screening (HTS) research. Their droplet microfluidics technology enables …See details»
Practica Capital
Atrandi Biosciences is transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology, enabling scalable, true single-cell multiomics. By simplifying complex …See details»
Atrandi Biosciences
Platforms for Semi–Permeable CapsulesAPPLICATION KITSSee details»
Atrandi Biosciences Raises $25M Series A Led by Lux Capital
Feb 19, 2025 Atrandi’s SPC technology eliminates these limitations by encapsulating individual cells in permeable compartments, allowing researchers to conduct bulk-like reactions while …See details»
Atrandi Biosciences Secures Funding and Advances Global ...
Apr 4, 2023 VILNIUS, Lithuania and DENVER, CO, March 23, 2023 – Backed by international investors, Atrandi Biosciences is establishing a direct team to support customers in the U.S. …See details»
Atrandi Biosciences Secures Funding and Advances Global ...
Mar 28, 2023 Backed by international investors, Atrandi Biosciences is establishing a direct team to support customers in the U.S. and advancing the global commercialization of its …See details»